Active immunization of mice with an Aβ-Hsp70 vaccine

Neurodegenerative Diseases

Volumn 1, Issue 1, 2004, Pages 20-28

  Koller, Michael F ^a   Mohajeri, M Hasan ^a   Huber, Michael ^a   Wollmer, M Axel ^a   Roth Z'graggen, Birgit V ^a   Sandmeier, Erika ^a   Moritz, Eva ^a   Tracy, Jay ^a   Nitsch, Roger M ^a   Christen, Philipp ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adjuvant; Alzheimer's disease; Chaperone; DnaK; Heat shock proteins; Immunization; Vaccination

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FORMIC ACID; HEAT SHOCK PROTEIN 70; PROTEIN DNAK; TRITON X 100;

ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BRAIN BLOOD VESSEL; COVALENT BOND; CROSS LINKING; ESCHERICHIA COLI; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SEQUENCE HOMOLOGY; TRANSGENIC ANIMAL;

ADJUVANTS, IMMUNOLOGIC; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SENILE PLAQUES; VACCINATION;

EID: 2342652903     PISSN: 16602854     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076666     Document Type: Article

References (54)

1. Hyman BT: The neuropathological diagnosis of Alzheimer's disease: Clinical-pathological studies. Neurobiol Aging 1997;18:S27-S32.
2. Walker LC, LeVine H: The cerebral proteopathies: Neurodegenerative disorders of protein conformation and assembly. Mol Neurobiol 2000;21:83-95.
3. Selkoe DJ: The genetics and molecular pathology of Alzheimer's disease: Roles of amyloid and the presenilins. Neurol Clin 2000;18:903-922.
4. 42(43). Neuron 1994;13:45-53.
5. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD: Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 2000;283:1571-1577.
6. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ: Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal longterm potentiation in vivo. Nature 2002;416:535-539.
7. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH: The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 2002;22:1858-1867.
8. Selkoe DJ: Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neurol 1994;53:438-447.
9. Golde TE, Houlden H: Biochemical detection of Aβ isoforms: Implications for pathogenesis, diagnosis and treatment of Alzheimer's disease. Biochim Biophys Acta 2000;1502:172-187.
10. Selkoe DJ: Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann NY Acad Sci 2000;924:17-25.
11. 42 fibrils. Science 2001;293:1491-1495.
12. Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, Mutter LC, Nietz J, Quinn KP, Sacchi KL, Seubert PA, Shopp GM, Thorsett ED, Tung JS, Wu J, Yang S, Yin CT, Schenk DB, May PC, Altstiel LD, Bender MH, Boggs LN, Britton TC, Clemens JC, Czilli DL, Dieckman-McGinty DK, Droste JJ, Fuson KS, Gitter BD, Hyslop PA, Johnstone EM, Li WY, Little SP, Mabry TE, Miller FD, Audia JE: Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain. J Neurochem 2001;76:173-181.
13. Soto C, Kindy MS, Baumann M, Frangione B: Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem Biophys Res Commun 1996;226:672-680.
14. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P: Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-177.
15. Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, Davey G, Moritz E, Nitsch RM: Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease. Nat Med 2002;8:1270-1275.
16. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D: Aβ-peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000;408:979-982.
17. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW: Aβ-peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000;408:982-985.
18. Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ: Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol 2000;48:567-579.
19. Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T: Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol 2001;159:439-447.
20. McLaurin J: Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat Med 2002;8:1263-1269.
21. Schenk D: Amyloid-β immunotherapy for Alzheimer's disease: The end of the beginning. Nat Rev Neurosci 2002;3:824-828.
22. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T: Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000;6:916-919.
23. Bacskai BJ, Kajdasz ST, Christie RH, Carter C, Games D, Seubert P, Schenk D, Hyman BT: Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med 2001;7:369-372.
24. Solomon B, Koppel R, Hanan E, Katzav T: Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide. Proc Natl Acad Sci USA 1996;93:452-455.
25. Solomon B: Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc Natl Acad Sci USA 1997;94:4109-4112.
26. Frenkel D, Balass M, Solomon B: N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodies. J Neuroimmunol 1998;88:85-90.
27. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM: Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2001;98:8850-8855.
28. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM: Brain to plasma amyloid-β efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 2002;295:2264-2267.
29. Arendash GW, Gordon MC, Diamond DM, Austin LA, Hatcher JM, Jantzen P, Dicarlo G, Wilcock D, Morgan D: Behavioral assessment of Alzheimer's transgenic mice following longterm Aβ vaccination: Task specificity and correlations between A deposition and spatial memory. DNA Cell Biol 2001;20:737-744.
30. Zügel U, Kaufmann SH: Immune response against heat-shock proteins in infectious diseases. Immunobiology 1999;201:22-35.
31. Zügel U, Kaufmann SH: Role of heat-shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12:19-39.
32. Wang XY, Kaneko Y, Repasky E, Subjeck JR: Heat-shock proteins and cancer immunotherapy. Immunol Invest 2000;29:131-137.
33. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK: Necrotic but not apoptotic cell death releases heat-shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int Immunol 2000;12:1539-1546.
34. Lehner T, Bergmeier LA, Wang Y, Tao L, Sing M, Spallek R, van der Zee R: Heat-shock proteins generate β-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol 2000;30:594-603.
35. Srivastava PK, Amato RJ: Heat-shock proteins: The 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 2001;19:2590-2597.
36. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 1996;274:99-102.
37. Mohajeri MH, Saini K, Schultz JG, Wollmer MA, Hock C, Nitsch RM: Passive immunization against β-amyloid peptide protects central nervous system neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation. J Biol Chem 2002;277:33012-33017.
38. Schmid D, Baici A, Gehring H, Christen P: Kinetics of molecular chaperone action. Science 1994;263:971-973.
39. 4. Nature 1970;227:680-685.
40. Koller MF, Grau T, Christen P: Generation of antibodies against full-length prion protein in wild-type mice. J Neuroimmunol 2002;132:113-116.
41. Wilcock DM, Gordon MN, Ugen KE, Gottschall PE, Dicarlo G, Dickey C, Boyett KW, Jantzen PT, Connor KE, Melachrino J, Hardy J, Morgan D: Number of Aβ inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation and congophilic plaque levels. DNA Cell Biol 2001;20:731-736.
42. Monsonego A, Maron R, Zota V, Selkoe DJ, Weiner HL: Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 2001;98:10273-10278.
43. Trieb K, Ransmayr G, Sgonc R, Lassmann H, Grubeck-Loebenstein B: APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol Aging 1996;17:541-547.
44. Craig EA, Gambill BD, Nelson RJ: Heat-shock proteins: Molecular chaperones of protein biogenesis. Microbiol Rev 1993;57:402-414.
45. Del Giudice G: Hsp70:A carrier molecule with built-in adjuvanticity. Experientia 1994;50:1061-1066.
46. Srivastava P: Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002;2:185-194.
47. Del Giudice G, Gervaix A, Costantino P, Wyler CA, Tougne C, de Graeff-Meeder ER, van Embden J, van der Zee R, Nencioni L, Rappuoli R: Priming to heat-shock proteins in infants vaccinated against pertussis. J Immunol 1993;150:2025-2032.
48. Regner M, Lambert PH: Autoimmunity through infection or immunization? Nat Immunol 2001;2:185-188.
49. Feige U, Cohen IR: The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice. Springer Semin Immunopathol 1991;13:99-113.
50. Noll A, Bucheler N, Bohn E, Autenrieth IB: Microbial heat-shock proteins as vaccine. Behring Inst Mitt 1997;98:87-98.
51. Menoret A, Chandawarkar RY, Srivastava PK: Natural autoantibodies against heat-shock proteins hsp70 and gp96. Immunology 2000;101:364-370.
52. Vehmas AK, Borchelt DR, Price DL, McCarthy D, Wills-Karp M, Peper MJ, Rudow G, Luyinbazi J, Siew LT, Troncoso JC: β-Amyloid peptide vaccination results in marked changes in serum and brain Aβ levels in APPswe/PS1ΔE9 mice, as detected by SELDI-TOF-based ProteinChip® technology. DNA Cell Biol 2001;20:713-721.
53. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG: Age-dependent changes in brain, CSF and plasma amyloid (β) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001;21:372-381.
54. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M: Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999;96:14088-14093.